| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 4 1973-1986, Copyright © 1995 by American Association of Immunologists
ARTICLES |
T Takeshita, H Takahashi, S Kozlowski, JD Ahlers, CD Pendleton, RL Moore, Y Nakagawa, K Yokomuro, BS Fox and DH Margulies
Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Although several peptides have been found to bind to both class I and class II molecules, the basis for this binding of the same peptide to two classes of MHC molecules has not been compared previously. We have analyzed one such peptide, P18 from the V3 loop of HIV-1 gp160, which we have previously shown to be recognized by CD8+ CTL with the class I molecule H-2Dd, and by CD4+ Th cells with the class II molecule I-Ad. With the use of truncated and substituted peptides, we found that the minimal core peptides are very similar, that the residues required for class I binding precisely fit the recently identified consensus motif for peptides binding to Dd (XGPX[R/K/H]XXX(X) [L/I/F]), and that at least three of the same residues are involved in binding to class II I- Ad. In addition, several of the same residues are involved in TCR interaction when the peptide is presented by class I and class II molecules. Modeling shows results to be consistent with the crystal structure of a peptide-class II MHC complex. Thus, the recognition of this versatile peptide by CD4+ Th cells with class II MHC molecules and by CD8+ cytotoxic T cells with class I MHC molecules is remarkably similar in both the core peptide used and the role of different residues in the ternary complex.
This article has been cited by other articles:
|
|
 |
|
  Y. Nakagawa, H. Kikuchi, and H. Takahashi Molecular Analysis of TCR and Peptide/MHC Interaction Using P18-I10-Derived Peptides with a Single D-Amino Acid Substitution Biophys. J., April 1, 2007; 92(7): 2570 - 2582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takamura, K. Matsuo, Y. Takebe, and Y. Yasutomi Ag85B of Mycobacteria Elicits Effective CTL Responses through Activation of Robust Th1 Immunity as a Novel Adjuvant in DNA Vaccine J. Immunol., August 15, 2005; 175(4): 2541 - 2547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kennedy, A. H. Undale, W. C. Kieper, M. S. Block, L. R. Pease, and E. Celis Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses J. Immunol., April 1, 2005; 174(7): 3967 - 3977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zeng, R. Spolski, S. E. Finkelstein, S. Oh, P. E. Kovanen, C. S. Hinrichs, C. A. Pise-Masison, M. F. Radonovich, J. N. Brady, N. P. Restifo, et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function J. Exp. Med., January 3, 2005; 201(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Samino, D. Lopez, S. Guil, P. de Leon, and M. Del Val An Endogenous HIV Envelope-derived Peptide without the Terminal NH3+ Group Anchor Is Physiologically Presented by Major Histocompatibility Complex Class I Molecules J. Biol. Chem., January 9, 2004; 279(2): 1151 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kushner, D. Zhang, N. Touzjian, M. Essex, J. Lieberman, and Y. Lu A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen PNAS, May 27, 2003; 100(11): 6652 - 6657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oh, J. A. Berzofsky, D. S. Burke, T. A. Waldmann, and L. P. Perera Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity PNAS, March 18, 2003; 100(6): 3392 - 3397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Hill, T. Kasliwal, E. Schwarz, A. M. Hebert, T. Chen, E. Gubina, L. Zhang, and S. Kozlowski A Dominant Negative Mutant beta 2-Microglobulin Blocks the Extracellular Folding of a Major Histocompatibility Complex Class I Heavy Chain J. Biol. Chem., February 14, 2003; 278(8): 5630 - 5638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, E. Osono, Y. Nakagawa, J. Wang, J. A. Berzofsky, D. H. Margulies, and H. Takahashi Rapid Induction of Apoptosis in CD8+ HIV-1 Envelope-Specific Murine CTLs by Short Exposure to Antigenic Peptide J. Immunol., December 1, 2002; 169(11): 6588 - 6593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ahlers, I. M. Belyakov, M. Terabe, R. Koka, D. D. Donaldson, E. K. Thomas, and J. A. Berzofsky A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L PNAS, October 1, 2002; 99(20): 13020 - 13025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Horner, S. K. Datta, K. Takabayashi, I. M. Belyakov, T. Hayashi, N. Cinman, M.-D. Nguyen, J. H. Van Uden, J. A. Berzofsky, D. D. Richman, et al. Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites J. Immunol., August 1, 2001; 167(3): 1584 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, I. M. Belyakov, M. A. Derby, J. Wang, L. F. Boyd, J. A. Berzofsky, and D. H. Margulies Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody J. Immunol., July 15, 2001; 167(2): 699 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Derby, J. Wang, D. H. Margulies, and J. A. Berzofsky Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining Int. Immunol., June 1, 2001; 13(6): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Derby, M. A. Alexander-Miller, R. Tse, and J. A. Berzofsky High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL J. Immunol., February 1, 2001; 166(3): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, Y. Nakagawa, J. A. Berzofsky, and H. Takahashi Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide Int. Immunol., January 1, 2001; 13(1): 43 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Belyakov, J. D. Ahlers, J. D. Clements, W. Strober, and J. A. Berzofsky Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL J. Immunol., December 1, 2000; 165(11): 6454 - 6462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Polakova, D. Plaksin, D. H. Chung, I. M. Belyakov, J. A. Berzofsky, and D. H. Margulies Antibodies Directed Against the MHC-I Molecule H-2Dd Complexed with an Antigenic Peptide: Similarities to a T Cell Receptor with the Same Specificity J. Immunol., November 15, 2000; 165(10): 5703 - 5712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Ramírez, M. M. Gherardi, D. Rodríguez, and M. Esteban Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector J. Virol., August 15, 2000; 74(16): 7651 - 7655. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Lu, R. Friedman, N. Kushner, A. Doling, L. Thomas, N. Touzjian, M. Starnbach, and J. Lieberman Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity PNAS, July 5, 2000; 97(14): 8027 - 8032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsui, J. D. Ahlers, A. O. Vortmeyer, M. Terabe, T. Tsukui, D. P. Carbone, L. A. Liotta, and J. A. Berzofsky A Model for CD8+ CTL Tumor Immunosurveillance and Regulation of Tumor Escape by CD4 T Cells Through an Effect on Quality of CTL J. Immunol., July 1, 1999; 163(1): 184 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Belyakov, B. Moss, W. Strober, and J. A. Berzofsky Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity PNAS, April 13, 1999; 96(8): 4512 - 4517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. White, F. Crawford, D. Fremont, P. Marrack, and J. Kappler Soluble Class I MHC with {beta}2-Microglobulin Covalently Linked Peptides: Specific Binding to a T Cell Hybridoma J. Immunol., March 1, 1999; 162(5): 2671 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Leggatt, A. Hosmalin, C. D. Pendleton, A. Kumar, S. Hoffman, and J. A. Berzofsky The Importance of Pairwise Interactions Between Peptide Residues in the Delineation of TCR Specificity J. Immunol., November 1, 1998; 161(9): 4728 - 4735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Alexander-Miller, M. A. Derby, A. Sarin, P. A. Henkart, and J. A. Berzofsky Supraoptimal Peptide-Major Histocompatibility Complex Causes a Decrease in Bcl-2 Levels and Allows Tumor Necrosis Factor alpha Receptor II-mediated Apoptosis of Cytotoxic T Lymphocytes J. Exp. Med., October 19, 1998; 188(8): 1391 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Belyakov, L. S. Wyatt, J. D. Ahlers, P. Earl, C. D. Pendleton, B. L. Kelsall, W. Strober, B. Moss, and J. A. Berzofsky Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein J. Virol., October 1, 1998; 72(10): 8264 - 8272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Correale, K. Walmsley, S. Zaremba, M. Zhu, J. Schlom, and K. Y. Tsang Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide J. Immunol., September 15, 1998; 161(6): 3186 - 3194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Belyakov, M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, and J. A. Berzofsky Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge PNAS, February 17, 1998; 95(4): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Goletz, K. R. Klimpel, N. Arora, S. H. Leppla, J. M. Keith, and J. A. Berzofsky Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein PNAS, October 28, 1997; 94(22): 12059 - 12064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ahlers, T. Takeshita, C. D. Pendleton, and J. A. Berzofsky Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence PNAS, September 30, 1997; 94(20): 10856 - 10861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, M. C. Whitman, K. Natarajan, J. Tormo, R. A. Mariuzza, and D. H. Margulies Binding of the Natural Killer Cell Inhibitory Receptor Ly49A to Its Major Histocompatibility Complex Class I Ligand. CRUCIAL CONTACTS INCLUDE BOTH H-2Dd AND beta 2-MICROGLOBULIN J. Biol. Chem., January 4, 2002; 277(2): 1433 - 1442. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
